| Field | Specification |
|---|---|
| Species | |
| Applications | |
| Cell type | |
| Classification | |
| Tissue | |
| Growth properties | |
| Biosafety level | |
| Catalog no. (Mfr.) | |
| Main SKU |
Overview
Human CD56+ NK cells are primary nk cells derived from human. Product metadata indicate an in vitro culture model and a reported BSL-2 handling context. Depending on the selected variant, the product may be supplied in selectable cryopreserved formats (Frozen Vial (1 x 10^6 cells)) for in vitro studies that benefit from tissue-relevant cellular context.
Key elements and design rationale
- Source and identity reflect the stated nk cells model and tissue origin.
- Reported classifications and phenotype descriptors include primary.
- Selectable variants can include Frozen Vial (1 x 10^6 cells); choose the listed format according to culture scale, handling preference, and downstream assay design.
- Handling considerations should follow institutional practice appropriate for the reported BSL-2 classification and the datasheet associated with the selected format.
Review the specification table and variant selector together when choosing the appropriate format for assay scale, tissue context, and downstream readouts.
Biological background
Natural killer cells are used in immune phenotyping, activation, and cytotoxicity-related studies. In this case, the stated source material and organ-system context can influence morphology, baseline signaling, and assay responsiveness.
Research relevance and current trends
- Tissue-specific cell-state differences remain important when selecting in vitro models for mechanistic and comparative studies.
- Researchers often combine morphological, molecular, and functional measurements to interpret phenotype in context.
- Comparisons across donor source, passage, tissue origin, or model state can help separate model-specific effects from assay-specific effects.
Common research applications
- Comparative cell-culture studies to track morphology, viability, or response to environmental cues.
- Molecular or imaging-based analyses to connect phenotype with pathway-level changes.
- Functional assays selected to match the stated tissue origin, cell type, and experimental question.
Changes in morphology, marker expression, proliferation, migration, barrier properties, reporter activity, or secreted factors are typically interpreted alongside matched controls and the selected culture conditions.
Notes for experimental interpretation
- Potential confounders include donor-to-donor variability, passage-dependent phenotypic drift, substrate effects, serum or media composition, and differences between cryopreserved and expansion-stage material.
- Use matched controls and confirm identity with morphology- and marker-based readouts suited to the stated cell type, tissue source, and downstream assay.
Customization & Add-ons: Can't find the cell line you need—or require a custom cell-based solution for your project? We can help you source the best match or support custom cell line services for diverse research needs, including cell line sourcing and selection (species, tissue, and disease model matching), stable cell line engineering (overexpression, knockdown, or knockout via CRISPR/Cas9, shRNA, or sgRNA), reporter gene integration (GFP, RFP, luciferase, and other fluorescent or bioluminescent constructs), genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles), inducible expression systems (Tet-On/Off and other regulatable constructs), drug resistance marker selection (puromycin, G418, hygromycin, and others), custom growth and media optimisation for specific assay requirements, scale-up production for high-throughput screening campaigns, and authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
